INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr | ₹373 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
Year | Revenue |
---|---|
Mar2024 | ₹1,081 Cr |
Mar2023 | ₹926 Cr |
Mar2022 | ₹801 Cr |
Mar2021 | ₹411 Cr |
Mar2020 | ₹373 Cr |
How is Revenue of INNOVA CAPTAB Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,081 Cr | 16.72 | |
Mar2023 | ₹926 Cr | 15.72 | |
Mar2022 | ₹801 Cr | 94.94 | |
Mar2021 | ₹411 Cr | 10.00 | |
Mar2020 | ₹373 Cr | - |
Compare Revenue of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹4,995.3 Cr | -1.9% | -3.8% | 73.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,824.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,355.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹122,929.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | -1.9% |
-3.8% |
73.7% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses